Benoı̂t J. Van den Eynde

16.0k citations

119 papers · 11.6k indexed · 5 hit papers · h-index 54

Co-authors: Thierry Boon Pierre van der Bruggen Vincent Stroobant Pierre G. Coulie Didier Colau Luc Pilotte Catherine Uyttenhove Ivan Théate
Topics: Immunotherapy and Immune Responses (72 papers)Immune Cell Function and Interaction (34 papers)Ubiquitin and proteasome pathways (25 papers)
Cited by: Biological Psychiatry Immunology Behavioral Neuroscience
Journals: Nature Science Proceedings of the National Academy of Sciences
Partner nations: Belgium France United Kingdom

In The Last Decade

Benoı̂t J. Van den Eynde

116 papers receiving 11.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

2003 1.8k citations Catherine Uyttenhove, Luc Pilotte et al. profile →
Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy

2014 845 citations Pierre G. Coulie, Benoı̂t J. Van den Eynde et al. profile →
Tryptophan Catabolism in Cancer: Beyond IDO and Tryptophan Depletion

2012 554 citations Benoı̂t J. Van den Eynde et al. Cancer Research profile →
T cell defined tumor antigens

1997 516 citations Benoı̂t J. Van den Eynde, Pierre van der Bruggen profile →
HUMAN T CELL RESPONSES AGAINST MELANOMA

2005 504 citations Thierry Boon, Pierre G. Coulie et al. profile →

Peers

Countries citing papers authored by Benoı̂t J. Van den Eynde

Since Specialization

Citations

This map shows the geographic impact of Benoı̂t J. Van den Eynde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benoı̂t J. Van den Eynde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benoı̂t J. Van den Eynde more than expected).

Fields of papers citing papers by Benoı̂t J. Van den Eynde

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benoı̂t J. Van den Eynde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benoı̂t J. Van den Eynde. The network helps show where Benoı̂t J. Van den Eynde may publish in the future.

Co-authorship network of co-authors of Benoı̂t J. Van den Eynde

This figure shows the co-authorship network connecting the top 25 collaborators of Benoı̂t J. Van den Eynde. A scholar is included among the top collaborators of Benoı̂t J. Van den Eynde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benoı̂t J. Van den Eynde. Benoı̂t J. Van den Eynde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Unlocking the mystery of the PD-1/PD-L1 axis: beyond the checkpoint hype 2025 ·Frontiers in Immunology ·(unknown),(unknown),Benoı̂t J. Van den Eynde,Jingjing Zhu	0
2	IFNγ-Induced PD-L1+MHCII+ Macrophages and Tim-3+ Tumor-Reactive CD8+ T Cells Predict a Response to Anti–PD-1 Therapy in Tumor-Bearing Mice 2025 ·Cancer Immunology Research ·(unknown),(unknown),(unknown),Sébastien Denanglaire,Abdulkader Azouz,Louis Boon,Benoı̂t J. Van den Eynde,Muriel Moser,Stanislas Goriely,Oberdan Léo	1
3	Novel H-2D^b-restricted CD8 epitope derived from mouse MAGE-type antigen P1A mediates antitumor immunity in C57BL/6 mice 2024 ·Journal for ImmunoTherapy of Cancer ·(unknown),Silvia Panetti,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Ramiro A. Ramirez-Valdez,Vineethkrishna Chandrasekar,(unknown),Vincent Stroobant,Nathalie Vigneron,Benoı̂t J. Van den Eynde,Carol S. Leung	0
4	Tryptophan depletion sensitizes the AHR pathway by increasing AHR expression and GCN2/LAT1-mediated kynurenine uptake, and potentiates induction of regulatory T lymphocytes 2023 ·Journal for ImmunoTherapy of Cancer ·(unknown),Pauline Pfänder,(unknown),Luc Pilotte,Vincent Stroobant,(unknown),Stefan Naulaerts,Quentin Spillier,Raphaël Frédérick,Etienne De Plaen,Christine Sers,Christiane A. Opitz,Benoı̂t J. Van den Eynde,Jingjing Zhu	53
5	1502TiP A phase I/IIa trial of ChAdOx1 and MVA vaccines against MAGE-A3 and NY-ESO-1 2023 ·Annals of Oncology ·Fiona Blackhall,(unknown),Adel Samson,K. Franks,Ioannis Karydis,Deborah Joseph-Pietras,Oliver Frank,Heather Lavender,(unknown),Margaret Marshall,(unknown),Benoı̂t J. Van den Eynde,Carol S. Leung,Adrian V. S. Hill,Mark R. Middleton,Nicholas Coupe,Nicola Steele,James Spicer,(unknown),Stefan N. Symeonides	3
6	T Cell–Mediated Targeted Delivery of Anti–PD-L1 Nanobody Overcomes Poor Antibody Penetration and Improves PD-L1 Blocking at the Tumor Site 2022 ·Cancer Immunology Research ·(unknown),(unknown),(unknown),Stefan Naulaerts,(unknown),Jean‐François Collet,Benoı̂t J. Van den Eynde,Jingjing Zhu	15
7	Preclinical murine tumor models: A structural and functional perspective 2020 ·eLife ·Marion V. Guérin,Veronica Finisguerra,Benoı̂t J. Van den Eynde,Nadège Bercovici,Alain Trautmann	92
8	Tryptophan 2,3-Dioxygenase Expression Identified in Human Hepatocellular Carcinoma Cells and in Intratumoral Pericytes of Most Cancers 2019 ·Cancer Immunology Research ·(unknown),(unknown),Vincent Stroobant,Caroline Bouzin,(unknown),(unknown),(unknown),(unknown),Jean‐Christophe Renauld,Nicolas van Baren,(unknown),Étienne Marbaix,Benoı̂t J. Van den Eynde	45
9	Inhibition of Tryptophan-Dioxygenase Activity Increases the Antitumor Efficacy of Immune Checkpoint Inhibitors 2019 ·Cancer Immunology Research ·(unknown),Stefano Crosignani,(unknown),(unknown),Luc Pilotte,Vincent Stroobant,(unknown),Grégory Driessens,Benoı̂t J. Van den Eynde	55
10	Influenza A Virus Infection Induces Viral and Cellular Defective Ribosomal Products Encoded by Alternative Reading Frames 2019 ·The Journal of Immunology ·Damien Zanker,(unknown),David C. Tscharke,Mubing Duan,(unknown),(unknown),Kun Xiao,Nicole A. Mifsud,James S. Gibbs,Leonard Izzard,Daniel Dlugolenski,Pierre Faou,Karen Laurie,Nathalie Vigneron,Ian Barr,John Stambas,Benoı̂t J. Van den Eynde,Jack R. Bennink,Jonathan W. Yewdell,Weisan Chen	21
11	Constitutive IDO1 Expression in Human Tumors Is Driven by Cyclooxygenase-2 and Mediates Intrinsic Immune Resistance 2017 ·Cancer Immunology Research ·Marc Hennequart,Luc Pilotte,Stefania Canè,(unknown),Vincent Stroobant,Etienne De Plaen,Benoı̂t J. Van den Eynde	137
12	Extensive Profiling of the Expression of the Indoleamine 2,3-Dioxygenase 1 Protein in Normal and Tumoral Human Tissues 2014 ·Cancer Immunology Research ·Ivan Théate,Nicolas van Baren,Luc Pilotte,Pierre Moulin,Pierre Larrieu,Jean‐Christophe Renauld,Caroline Hervé,Ilse Gutierrez-Roelens,Étienne Marbaix,Christine Sempoux,Benoı̂t J. Van den Eynde	284
13	Antigen Spreading Contributes to MAGE Vaccination-Induced Regression of Melanoma Metastases 2011 ·Cancer Research ·Véronique Corbière,Jacques Chapiro,Vincent Stroobant,Wenbin Ma,Christophe Lurquin,Bernard Lethé,Nicolas van Baren,Benoı̂t J. Van den Eynde,Thierry Boon,Pierre G. Coulie	142
14	An Inducible Mouse Model of Melanoma Expressing a Defined Tumor Antigen 2006 ·Cancer Research ·Ivo J. Huijbers,Paul Krimpenfort,Patrick Chomez,Martin A. van der Valk,(unknown),Else-Marit Inderberg-Suso,Anne‐Marie Schmitt‐Verhulst,Anton Berns,Benoı̂t J. Van den Eynde	40
15	An Antigen Produced by Splicing of Noncontiguous Peptides in the Reverse Order 2006 ·Science ·Edus H. Warren,Nathalie Vigneron,Marc A. Gavin,Pierre G. Coulie,Vincent Stroobant,Alexandre Dalet,Scott S. Tykodi,(unknown),Jeffrey K. Mito,Stanley R. Riddell,Benoı̂t J. Van den Eynde	160
16	Destructive Cleavage of Antigenic Peptides Either by the Immunoproteasome or by the Standard Proteasome Results in Differential Antigen Presentation 2006 ·The Journal of Immunology ·Jacques Chapiro,Stéphane Claverol,Fanny Piette,Wenbin Ma,Vincent Stroobant,Benoît Guillaume,(unknown),Sandra Morel,Odile Burlet‐Schiltz,Bernard Monsarrat,Thierry Boon,Benoı̂t J. Van den Eynde	125
17	An Antigenic Peptide Produced by Peptide Splicing in the Proteasome 2004 ·Science ·Nathalie Vigneron,Vincent Stroobant,Jacques Chapiro,Annie Ooms,Gérard Degiovanni,Sandra Morel,Pierre van der Bruggen,Thierry Boon,Benoı̂t J. Van den Eynde	262
18	TNF-Mediated Toxicity After Massive Induction of Specific CD8+ T Cells Following Immunization of Mice with a Tumor-Specific Peptide 2002 ·The Journal of Immunology ·Janine Bilsborough,Catherine Uyttenhove,Didier Colau,Philippe Bousso,Claude Libert,Birgit Weynand,Thierry Boon,Benoı̂t J. Van den Eynde	17
19	The Final N-Terminal Trimming of a Subaminoterminal Proline-Containing HLA Class I-Restricted Antigenic Peptide in the Cytosol Is Mediated by Two Peptidases 2002 ·The Journal of Immunology ·Frédéric Lévy,Lena Burri,Sandra Morel,(unknown),Nicole Lévy,Angela Bachi,Ulf Hellman,Benoı̂t J. Van den Eynde,Catherine Servis	67
20	Cytolytic T Lymphocytes Raised Against a Human Bladder Carcinoma Recognize an Antigen Encoded by Gene MAGE-A12 2000 ·The Journal of Immunology ·(unknown),Francis Brasseur,Michael Probst‐Kepper,(unknown),Thierry Boon,Benoı̂t J. Van den Eynde	38

About Benoı̂t J. Van den Eynde

Benoı̂t J. Van den Eynde is a scholar working on Biological Psychiatry, Immunology and Behavioral Neuroscience, having authored 119 papers that have together received 11.6k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (72 papers), Immune Cell Function and Interaction (34 papers) and Ubiquitin and proteasome pathways (25 papers). The work is most often cited by research in Biological Psychiatry (2.1k citations), Immunology (6.9k citations) and Behavioral Neuroscience (622 citations). Benoı̂t J. Van den Eynde has collaborated with scholars based in Belgium, France and United Kingdom. Frequent co-authors include Thierry Boon, Pierre van der Bruggen, Vincent Stroobant, Pierre G. Coulie, Didier Colau, Luc Pilotte, Catherine Uyttenhove, Ivan Théate, Nicolas Parmentier and Nathalie Vigneron. Their work appears in journals such as Nature, Science and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact